Condition: Severe Asthma · Sponsor: Generate Biomedicines
The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma that is uncontrolled by inhaled corticosteroids (ICS) and conventional asthma controllers. The study details include: Study treatment: randomized to receive either GB-0895 or placebo administered every 6 months over 52 weeks. Visit frequency: every 1-2 months after the first month.
This description comes directly from the study's public registry record.
Generate Recruitment · 888-469-0033 · solairiastudy@generatebiomedicines.com
Always discuss trial participation with your own doctor first.
| Research Site 23 | Northridge, California, United States | Recruiting |
| Research Site 26 | Pasadena, California, United States | Recruiting |
| Research Site 29 | Rancho Cucamonga, California, United States | Recruiting |
| Research Site 34 | Valencia, California, United States | Recruiting |
| Research Site 13 | West Hills, California, United States | Recruiting |
| Research Site 15 | Colorado Springs, Colorado, United States | Recruiting |
| Research Site 32 | Brooksville, Florida, United States | Recruiting |
| Research Site 12 | Doral, Florida, United States | Recruiting |
| Research Site 14 | Gainesville, Florida, United States | Recruiting |
| Research Site 03 | Hialeah, Florida, United States | Recruiting |
| Research Site 25 | Kendall, Florida, United States | Recruiting |
| Research Site 04 | Miami, Florida, United States | Recruiting |
+ 41 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07276724